Diabetic neuropathy: a cross-sectional study of the relationships among tests of neurophysiology

Christopher H Gibbons, Roy Freeman, Aristidis Veves, Christopher H Gibbons, Roy Freeman, Aristidis Veves

Abstract

Objective: To determine the relationships among large, small, and autonomic fiber neurophysiological measures in a cross-sectional study of patients with diabetes.

Research design and methods: We assessed 130 individuals: 25 healthy subjects and 105 subjects with diabetes. Subjects were classified by the presence or absence of neuropathy by physical examination. All subjects underwent autonomic testing, nerve conduction studies, quantitative sensory testing, and nerve-axon reflex vasodilation in addition to quantifiable neurological examination and symptom scores. Correlation and cluster analysis were used to determine relationships between and among different neurophysiological testing parameters.

Results: Results of neurophysiological tests were abnormal in patients with clinical evidence of diabetic neuropathy compared with results in healthy control subjects and in those without neuropathy (P < 0.01, all tests). The correlations among individual tests varied widely, both within (r range <0.5->0.9, NS to <0.001) and between test groups (r range <0.2->0.5, NS to <0.01). A two-step hierarchical cluster analysis revealed that neurophysiological tests do not aggregate by typical "small," "large," or "autonomic" nerve fiber subtypes.

Conclusions: The modest correlation coefficients seen between the different testing modalities suggest that these techniques measure different neurophysiological parameters and are therefore not interchangeable. However, the data suggest that only a small number of neurophysiological tests are actually required to clinically differentiate individuals with neuropathy from those without. The natural clustering of both patients and healthy control subjects suggests that variations in the population will need to be considered in future studies of diabetic neuropathy.

Figures

Figure 1
Figure 1
A dendrogram highlighting the association between tests using a two-step hierarchical cluster analysis. Tests that cluster more closely together, such as the monofilament of the left and right legs, reveal more similar test results. Many tests follow expected clustering, such as heat-pain detection in the hand and foot, sural amplitude and velocity, and systolic and diastolic blood pressures. Other tests that were expected to be more similar, such as vibration detection and nerve conduction studies, were not.
Figure 2
Figure 2
This figure reports eight clusters (C1–C8) of individuals from the study. The numbers of healthy control and diabetic subjects with and without neuropathy are shown for each cluster. Clusters 1–4 are made up of healthy control subjects and subjects without neuropathy, whereas clusters 5–8 are made up of individuals with neuropathy. The tests that contributed to the formation of these clusters are listed in the lower portion of the table, with circle size demonstrating the relative weight of each test toward a particular cluster assignment: the larger the circle, the greater the weight. Black indicates a more normal (i.e., better) result, and white indicates a more abnormal (i.e., worse) result. For example, the large black circle on vibration detection at the toe indicates that a good result was the single most important factor in assigning individuals to cluster 1. Cluster 1 seems to be made up of individuals with entirely normal responses; clusters 2 and 4 are individuals with normal sensation and autonomic testing but some reduced vasomotor blood flow. Cluster 3 contains healthy individuals who have some decreased cold-pain detection. Cluster 5 indicates individuals with modest neuropathy across all neurophysiologic tests, while cluster 7 indicates those with autonomic neuropathy. Cluster 6 indicated significant neuropathy across all neurophysiologic tests with predominant “small nerve fiber” dysfunction, while cluster 8 indicates more “large nerve fiber” dysfunction.

References

    1. Albers JW, Brown MB, Sima AA, Greene DA: Nerve conduction measures in mild diabetic neuropathy in the Early Diabetes Intervention Trial: the effects of age, sex, type of diabetes, disease duration, and anthropometric factors. Tolrestat Study Group for the Early Diabetes Intervention Trial. Neurology 1996;46:85–91
    1. Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial. Ann Neurol 1995;38:869–880
    1. Freeman R: Autonomic peripheral neuropathy. Lancet 2005;365:1259–1270
    1. Hamdy O, Abou-Elenin K, LoGerfo FW, Horton ES, Veves A: Contribution of nerve-axon reflex-related vasodilation to the total skin vasodilation in diabetic patients with and without neuropathy. Diabetes Care 2001;24:344–349
    1. Shy ME, Frohman EM, So YT, Arezzo JC, Cornblath DR, Giuliani MJ, Kincaid JC, Ochoa JL, Parry GJ, Weimer LH: Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2003;60:898–904
    1. Vinik AI, Ziegler D: Diabetic cardiovascular autonomic neuropathy. Circulation 2007;115:387–397
    1. Pham H, Armstrong DG, Harvey C, Harkless LB, Giurini JM, Veves A: Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. Diabetes Care 2000;23:606–611
    1. Bril V, Ellison R, Ngo M, Bergstrom B, Raynard D, Gin H: Electrophysiological monitoring in clinical trials. Roche Neuropathy Study Group [see comments] Muscle Nerve 1998;21:1368–1373
    1. Bril V, Kojic J, Ngo M, Clark K: Comparison of a neurothesiometer and vibration in measuring vibration perception thresholds and relationship to nerve conduction studies. Diabetes Care 1997;20:1360–1362
    1. Caselli A, Spallone V, Marfia GA, Battista C, Pachatz C, Veves A, Uccioli L: Validation of the nerve axon reflex for the assessment of small nerve fibre dysfunction. J Neurol Neurosurg Psychiatry 2006;77:927–932
    1. Veves A, Uccioli L, Manes C, Van Acker K, Komninou H, Philippides P, Katsilambros N, De Leeuw I, Menzinger G, Boulton AJ: Comparison of risk factors for foot problems in diabetic patients attending teaching hospital outpatient clinics in four different European states. Diabet Med 1994;11:709–713
    1. Veves A, Manes C, Murray HJ, Young MJ, Boulton AJ: Painful neuropathy and foot ulceration in diabetic patients. Diabetes Care 1993;16:1187–1189
    1. Donaghue VM, Giurini JM, Rosenblum BI, Weissman PN, Veves A: Variability in function measurements of three sensory foot nerves in neuropathic diabetic patients. Diabetes Res Clin Pract 1995;29:37–42
    1. Yarnitsky D: Quantitative sensory testing [see comments]. Muscle Nerve 1997;20:198–204
    1. Hilz MJ, Stemper B, Axelrod FB, Kolodny EH, Neundörfer B: Quantitative thermal perception testing in adults. J Clin Neurophysiol 1999;16:462–471
    1. Gibbons C, Freeman R: The evaluation of small fiber function—autonomic and quantitative sensory testing. Neurol Clin 2004;22:683–702, vii
    1. Low PA: Testing the autonomic nervous system. Semin Neurol 2003;23:407–421
    1. Doupis J, Lyons TE, Wu S, Gnardellis C, Dinh T, Veves A: Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy. J Clin Endocrinol Metab 2009;94:2157–2163
    1. Veves A, Akbari CM, Primavera J, Donaghue VM, Zacharoulis D, Chrzan JS, DeGirolami U, LoGerfo FW, Freeman R: Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes 1998;47:457–463
    1. Dyck PJ, Litchy WJ, Daube JR, Harper CM, Dyck PJ, Davies J, O'Brien PC: Individual attributes versus composite scores of nerve conduction abnormality: sensitivity, reproducibility, and concordance with impairment. Muscle Nerve 2003;27:202–210
    1. Kincaid JC, Price KL, Jimenez MC, Skljarevski V: Correlation of vibratory quantitative sensory testing and nerve conduction studies in patients with diabetes. Muscle Nerve 2007;36:821–827
    1. Freeman R, Chase KP, Risk MR: Quantitative sensory testing cannot differentiate simulated sensory loss from sensory neuropathy. Neurology 2003;60:465–470
    1. Gordon Smith A, Robinson Singleton J: Idiopathic neuropathy, prediabetes and the metabolic syndrome. J Neurol Sci 2006;242:9–14
    1. Vincent AM, Hinder LM, Pop-Busui R, Feldman EL: Hyperlipidemia: a new therapeutic target for diabetic neuropathy. J Peripher Nerv Syst 2009;14:257–267
    1. Wiggin TD, Sullivan KA, Pop-Busui R, Amato A, Sima AA, Feldman EL: Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes 2009;58:1634–1640

Source: PubMed

3
Subscribe